ALIMERA SCIENCES, INC. — Revenue by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/a20e136d-8343-4074-878e-8b24f213842b/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2023 | $80.8M | 2023-01-01 – 2023-12-31 | evidence 0001267602-24-000019 |
| FY 2022 | $54.1M | 2022-01-01 – 2022-12-31 | evidence 0001267602-23-000027 |
| FY 2021 | $59.0M | 2021-01-01 – 2021-12-31 | evidence 0001267602-22-000013 |
| FY 2020 | $50.8M | 2020-01-01 – 2020-12-31 | evidence 0001267602-21-000013 |
| FY 2019 | $53.9M | 2019-01-01 – 2019-12-31 | evidence 0001267602-20-000029 |
| FY 2018 | $46.6M | 2018-01-01 – 2018-12-31 | evidence 0001267602-20-000029 |
| FY 2017 | $35.9M | 2017-01-01 – 2017-12-31 | evidence 0001267602-19-000043 |
| FY 2016 | $34.3M | 2016-01-01 – 2016-12-31 | evidence 0001267602-17-000021 |
| FY 2015 | $22.4M | 2015-01-01 – 2015-12-31 | evidence 0001267602-16-000119 |
| FY 2014 | $8.4M | 2014-01-01 – 2014-12-31 | evidence 0001267602-15-000018 |
| FY 2013 | $1.9M | 2013-01-01 – 2013-12-31 | evidence 0001267602-14-000015 |
| FY 2012 | $0 | 2012-01-01 – 2012-12-31 | evidence 0001267602-14-000015 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ALIMERA SCIENCES, INC. — all facts · Net Income · Operating Income